High Dose Intravitreal Bevacizumab for Refractory Pigment Epithelial Detachment in Age-related Macular Degeneration
Authors:
Open Access
- 1 January 2016
- journal article
- Published by Korean Ophthalmological Society in Korean Journal of Ophthalmology
- Vol. 30 (4) , 265-271
Abstract
Lee DK, et al. Korean J Ophthalmol. 2016 Aug;30(4):265-271. http://dx.doi.org/10.3341/kjo.2016.30.4.265Keywords
This publication has 33 references indexed in Scilit:
- Intravitreal Ranibizumab for Pigment Epithelium Detachment With Subfoveal Occult Choroidal Neovascularization: A Prospective 24-Month Case SeriesAmerican Journal of Ophthalmology, 2013
- High-dose ranibizumab therapy for vascularized pigment epithelial detachmentEye, 2012
- Ranibizumab and Bevacizumab for Neovascular Age-Related Macular DegenerationNew England Journal of Medicine, 2011
- INTRAVITREAL BEVACIZUMAB IN VASCULAR PIGMENT EPITHELIUM DETACHMENT AS A RESULT OF SUBFOVEAL OCCULT CHOROIDAL NEOVASCULARIZATION IN AGE-RELATED MACULAR DEGENERATIONRetina, 2010
- RETINAL PIGMENT EPITHELIAL TEARS AFTER INTRAVITREAL BEVACIZUMAB INJECTION FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATIONRetina, 2007
- INTRAVITREAL BEVACIZUMAB FOR REFRACTORY PIGMENT EPITHELIAL DETACHMENT WITH OCCULT CHOROIDAL NEOVASCULARIZATION IN AGE-RELATED MACULAR DEGENERATIONRetina, 2007
- Effect of systemic bevacizumab therapy on retinal pigment epithelial detachmentBritish Journal of Ophthalmology, 2006
- Ranibizumab for Neovascular Age-Related Macular DegenerationNew England Journal of Medicine, 2006
- SAFETY OF INTRAVITREAL INJECTION OF BEVACIZUMAB IN RABBIT EYESRetina, 2006
- Retinal pigment epithelial detachments in the elderly: classification and outcome.British Journal of Ophthalmology, 1985